Mercado Terapêutico Digital da América do Norte (DTx) – Tendências do setor e previsão para 2028

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado Terapêutico Digital da América do Norte (DTx) – Tendências do setor e previsão para 2028

  • Healthcare IT
  • Publish Reports
  • Feb 2021
  • North America
  • 350 Páginas
  • Número de tabelas: 61
  • Número de figuras: 36

>Mercado terapêutico digital da América do Norte (DTx), por produto e tipo de serviço (produtos de hardware, soluções/software, serviço), aplicação (aplicações relacionadas com tratamento/cuidados, aplicações preventivas), modo de compra (organização de compra em grupo, individual), canal de vendas (B2B, B2C), Tendências e previsões da indústria por país (EUA, Canadá, México) para 2028

Mercado Terapêutico Digital da América do Norte (DTx)Análise de mercado e insights: Mercado Terapêutico Digital (DTx) da América do Norte

Espera-se que o mercado terapêutico digital (DTx) ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 23,4% no período de previsão de 2021 a 2028 e prevê-se que atinja os 10.639,36 milhões de dólares até 2028. O aumento da prevalência de doenças crónicas como a diabetes, hipertensão, entre outras, bem como a crescente consciencialização das agências governamentais aumentarão o crescimento do mercado terapêutico digital (DTx).

A terapêutica digital (DTx) oferece intervenções terapêuticas diretamente aos doentes, utilizando software baseado em evidências e avaliado remotamente para servir, gerir e evitar um amplo espectro de perturbações comportamentais, mentais e físicas. São utilizados isoladamente ou misturados com medicamentos, dispositivos ou outras terapias para otimizar os cuidados prestados aos doentes e os resultados de saúde. O aumento do acesso remoto a terapêuticas clinicamente testadas como seguras e eficazes é uma das propriedades da terapêutica digital (DTx) durante o tratamento.

O avanço tecnológico que as empresas fazem para alargar a sua linha de produtos e obter lucros é um dos impulsionadores do crescimento do mercado terapêutico digital (DTx). As preocupações com a privacidade relacionadas com as aplicações terapêuticas digitais (DTx) podem atuar como uma restrição para o crescimento do mercado terapêutico digital (DTx). A colaboração entre empresas ajudará no crescimento do mercado e servirá de oportunidade para o mercado terapêutico digital (DTx). A qualidade da terapêutica digital (DTx) deve ser mantida para proporcionar um melhor tratamento e um atendimento adequado aos clientes, por isso, esta necessita de ser feita de forma correta, pois esta funcionaria como um desafio para o mercado da terapêutica digital (DTx), pois muitos às vezes a necessidade não é satisfeita.   

O relatório do mercado terapêutico digital (DTx) fornece detalhes da quota de mercado, novos desenvolvimentos e análise do pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado terapêutico digital (DTx), contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.

Mercado Terapêutico Digital da América do Norte (DTx)Âmbito do mercado terapêutico digital (DTx) e dimensão do mercado

The digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service. In 2021, solutions/software segment is expected to dominate the market since there are number of smart phone users being increased.
  • On the basis of application, the digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications. In 2021, treatment/care-related applications segment is expected to dominate since it provides a good treatment and improve the life style of the people.   
  • On the basis of purchase mode, the digital therapeutic (DTx) market is segmented into group purchase organization and individual. In 2021, individual segment is expected to dominate the market since many people individually are accepting the digital healthcare platform and preferring them in the pandemic situation.
  • On the basis of sales channel, the digital therapeutic (DTx) market is segmented into B2B and B2C. In 2021, B2C segment is expected to dominate the market since the services are mostly preferred directly to the customers.

North America Digital Therapeutic (DTx) Market Country Level Analysis

North America digital therapeutic (DTx) market is analysed and market size information is provided by the country, product and service type, application, purchase mode and sales channel as referenced above.  

The countries covered in the North America digital therapeutic (DTx) market report are the U.S., Canada and Mexico.  

North America region holds the majority of the share in the digital therapeutic (DTx) market and is expected to witness the CAGR during the forecast period due to increasing number of cases in diabetes. The U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including digital therapeutic (DTx) products

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

As Iniciativas Estratégicas dos Fabricantes estão a criar novas oportunidades para os players do Mercado Terapêutico Digital (DTx)

O mercado terapêutico digital (DTx) também fornece análises de mercado detalhadas para o crescimento de cada país nas vendas de produtos terapêuticos digitais (DTx), impacto do avanço na terapêutica digital (DTx) e mudanças nos cenários regulamentares com o seu apoio à terapêutica digital ( mercado DTx). Os dados estão disponíveis para o período histórico de 2011 a 2019.

Análise do cenário competitivo e da participação no mercado terapêutico digital (DTx)

O cenário competitivo do mercado terapêutico digital (DTx) fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura e amplitude do produto, domínio de aplicação, curva de segurança da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco da empresa relacionado com o mercado terapêutico digital (DTx).

Os principais players abrangidos no relatório do mercado terapêutico digital (DTx) da América do Norte são a Fitbit, Inc., Livongo, ResMed, Omada Health, Inc., Noom, Inc., Happify, Inc., Welldoc, Inc., SAMSUNG, ATENTIV, MANGO HEALTH, CogniFit, Kaia Health, Mindstrong Health, Smart Patient gmbh, Ayogo Health Inc., Ginger, Better Therapeutics, Inc., 2Morrow Inc., CANARY HEALTH, Click Therapeutics, Inc., Cognoa, Pear Therapeutics, Inc. , Voluntis, Akili Interactive Labs, Inc. entre outros players nacionais. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

Muitos lançamentos e acordos de produtos são também iniciados por empresas de todo o mundo que também estão a acelerar o mercado terapêutico digital (DTx).

Por exemplo,

  • Em agosto de 2019, a ATENTIV assinou um acordo com o Centro Hospitalar Especializado Infantil. A colaboração entre ambos compreende o co-desenvolvimento de um sistema operacional unificado de tratamento comportamental e básico que utiliza as melhores práticas clínicas para a transmissão da mente ATENTIV pelos médicos de cuidados primários. Esta colaboração aumentaria o valor da marca da empresa e o valor de mercado do produto.

A colaboração, o lançamento de produtos, a expansão do negócio, a premiação e reconhecimento, as joint ventures e outras estratégias dos players do mercado estão a potenciar o mercado da empresa no mercado terapêutico digital (DTx), que também oferece o benefício para a organização melhorar a sua oferta de terapêutica digital (DTx) ).   

 

 


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 NORTH AMERICA DIGITAL THERAPEUTICS (DTX) MARKET: REGULATIONS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES

5.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES

5.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE

5.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES

5.1.5 IMPROVED QUALITY OF LIFE

5.2 RESTRAINTS

5.2.1 PATIENT INFORMATION PRIVACY POLICIES

5.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS

5.2.3 UNDER DEVELOPING COUNTIRES LACKING SMARTPHONES AND INTERNET FACILITIES

5.3 OPPORTUNITIES

5.3.1 RISING DEMAND OF DIGITAL THERAPEUTICS

5.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES

5.3.3 PARTNERSHIP BETWEEN COMPANIES

5.3.4 EXPANSION AND LAUNCH OF PRODUCTS

5.3.5 EVENTS AND EXHIBITION

5.3.6 PHYSICIAN ADOPTION

5.4 CHALLENGES

5.4.1 CLINICAL VALIDATION

5.4.2 REGULATORY APPROVAL

5.4.3 PAYER REIMBURSEMENT

6 IMPACT OF COVID-19 ON NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

6.1 IMPACT ON DEMAND

6.2 IMPACT ON SUPPLY

6.3 KEY INITIATIVES TAKEN BY PLAYERS DURING COVID-19

6.4 CONCLUSION

7 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE

7.1 OVERVIEW

7.2 SOLUTION/SOFTWARE

7.3 HARDWARE PRODUCTS

7.4 SERVICE

8 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 TREATMENT/CARE-RELATED APPLIACTIONS

8.2.1 DIABETES

8.2.2 CENTRAL NERVOUS SYSTEM DISORDERS

8.2.3 SMOKING CESSATION

8.2.4 CHRONIC RESPIRATORY DISEASES

8.2.5 MUSCULOSKELETAL DISORDER

8.2.6 CARDIOVASCULAR DISEASES

8.2.7 MEDICATION ADHERENCE

8.2.8 GASTROINTESTINAL DISORDERS

8.2.9 REHABILITATION AND PATIENT CARE

8.2.10 SUBSTANCE USE DISORDER AND ADDICTION MANAGEMENT

8.2.11 OTHER TREATMENT/ CARE RELATED APPLICATIONS

8.3 PREVENTIVE APPLICATIONS

8.3.1 PREDIABETES

8.3.2 OBESITY

8.3.3 NUTRITION

8.3.4 LIFESTYLE MANAGEMENT

8.3.5 OTHER PREVENTIVE APPLICATIONS

9 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE

9.1 OVERVIEW

9.2 GROUP PURCHASE ORGANIZATION

9.2.1 SOLUTIONS/ SOFTWARE

9.2.2 HARDWARE PRODUCT

9.2.3 SERVICE

9.3 INDIVIDUAL

9.3.1 SOLUTIONS/ SOFTWARE

9.3.2 HARDWARE PRODUCT

9.3.3 SERVICE

10 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL

10.1 OVERVIEW

10.2 B2B

10.2.1 PAYERS

10.2.2 EMPLOYERS

10.2.3 PHARMA COMPANIES

10.2.4 PROVIDERS

10.2.5 OTHER BUYERS

10.3 B2C

10.3.1 CAREGIVERS

10.3.2 PATIENTS

11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY GEOGRAPHY

11.1 NORTH AMERICA

11.1.1 U.S.

11.1.2 CANADA

11.1.3 MEXICO

12 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 SWOT

14 COMPANY PROFILE

14.1 FITBIT,INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 LIVONGO

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 RESMED

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 OMADA HEALTH, INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 COMPANY SHARE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 GINGER

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENT

14.6 SAMSUNG

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.7 MINDSTRONG HEALTH

14.7.1 COMPANY SNAPSHOT

14.7.2 SERVICE PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 2MORROW INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 AKILI INTERACTIVE LABS, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 ATENTIV

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 AYOGO HEALTH INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 BETTER THERAPEUTICS, INC

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 CANARY HEALTH

14.13.1 COMPANY SNAPSHOT

14.13.2 SOLUTION PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 CLICK THERAPEUTICS, INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 COGNIFIT

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.16 COGNOA

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 GAIA AG

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENTS

14.18 HAPPIFY, INC.

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENTS

14.19 KAIA HEALTH

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 MANGO HEALTH

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENTS

14.21 NATURAL CYCLES USA CORP

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENT

14.22 NOOM, INC.

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENT

14.23 PEAR THERAPEUTICS, INC.

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENTS

14.24 SMARTPATIENT GMBH

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENT

14.25 VOLUNTIS

14.25.1 COMPANY SNAPSHOT

14.25.2 REVENUE ANALYSIS

14.25.3 PRODUCT PORTFOLIO

14.25.4 RECENT DEVELOPMENTS

14.26 WELLDOC, INC.

14.26.1 COMPANY SNAPSHOT

14.26.2 PRODUCT PORTFOLIO

14.26.3 RECENT DEVELOPMENTS

14.27 WELLTHY THERAPEUTICS PVT LTD

14.27.1 COMPANY SNAPSHOT

14.27.2 PRODUCT PORTFOLIO

14.27.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

Lista de Tabela

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)

TABLE 3 NORTH AMERICA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))

TABLE 4 NORTH AMERICA HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)

TABLE 7 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)

TABLE 12 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)

TABLE 17 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 32 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 33 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 34 U.S. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 U.S. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 36 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 37 U.S. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 38 U.S. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 39 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 40 U.S. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 U.S. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 42 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 43 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 44 CANADA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 CANADA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 46 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 47 CANADA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 48 CANADA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 49 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 50 CANADA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 CANADA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 52 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 53 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 MEXICO TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 MEXICO PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 56 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 57 MEXICO GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 58 MEXICO INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 59 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 60 MEXICO B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 MEXICO B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

 

Lista de Figura

LIST OF FIGURES

FIGURE 1 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET : DATA TRIANGULATION

FIGURE 3 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION

FIGURE 12 INCREASING DEMAND OF DIGITAL THERAPEUTICS WORLDWIDE DUE TO PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2021 TO 2028.

FIGURE 13 SOLUTIONS/SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

FIGURE 15 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020

FIGURE 16 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)

FIGURE 17 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2021-2028)

FIGURE 18 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE

FIGURE 19 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020

FIGURE 20 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020-2028 (USD MILLION)

FIGURE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020

FIGURE 24 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020-2028 (USD MILLION)

FIGURE 25 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2021-2028)

FIGURE 26 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 27 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020

FIGURE 28 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020-2028 (USD MILLION)

FIGURE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2021-2028)

FIGURE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE

FIGURE 31 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2020)

FIGURE 32 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020)

FIGURE 33 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2021 & 2028)

FIGURE 34 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020 & 2028)

FIGURE 35 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE (2021-2028)

FIGURE 36 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2020 (%)

 

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The North America Digital Therapeutic (DTx) Market will witness a 23.4% CAGR forecast by 2028.
The North America Digital Therapeutic (DTx) Market values at $10,639.36 million by 2028.
The countries covered in the North America digital therapeutic (DTx) market report are the U.S., Canada, and Mexico.
North America region holds the majority of the share in the digital therapeutic (DTx) market and is expected to witness the CAGR during the forecast period due to increasing number of cases in diabetes.